vs
CarGurus, Inc.（CARG）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
CarGurus, Inc.的季度营收约是Ultragenyx Pharmaceutical Inc.的1.0倍（$209.1M vs $207.3M），CarGurus, Inc.净利率更高（23.8% vs -62.0%，领先85.8%），Ultragenyx Pharmaceutical Inc.同比增速更快（25.9% vs -8.5%），CarGurus, Inc.自由现金流更多（$81.9M vs $-100.8M），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs -1.6%）
CarGurus是一家汽车研究与选购平台，在美国、英国和加拿大开展业务，为消费者和汽车经销商提供新二手车本地车源对比服务，同时支持用户与卖家直接联系，帮助购车群体高效适配心仪车辆，也为经销商搭建了精准的客户对接渠道。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
CARG vs RARE — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $209.1M | $207.3M |
| 净利润 | $49.8M | $-128.6M |
| 毛利率 | — | — |
| 营业利润率 | 57.0% | -54.7% |
| 净利率 | 23.8% | -62.0% |
| 营收同比 | -8.5% | 25.9% |
| 净利润同比 | 8.5% | 3.5% |
| 每股收益（稀释后） | $0.51 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $209.1M | $207.3M | ||
| Q3 25 | $238.7M | $159.9M | ||
| Q2 25 | $234.0M | $166.5M | ||
| Q1 25 | $225.2M | $139.3M | ||
| Q4 24 | $228.5M | $164.6M | ||
| Q3 24 | $231.4M | $139.5M | ||
| Q2 24 | $218.7M | $147.0M | ||
| Q1 24 | $215.8M | $108.8M |
| Q4 25 | $49.8M | $-128.6M | ||
| Q3 25 | $44.7M | $-180.4M | ||
| Q2 25 | $22.3M | $-115.0M | ||
| Q1 25 | $39.0M | $-151.1M | ||
| Q4 24 | $45.9M | $-133.2M | ||
| Q3 24 | $22.5M | $-133.5M | ||
| Q2 24 | $-68.7M | $-131.6M | ||
| Q1 24 | $21.3M | $-170.7M |
| Q4 25 | — | — | ||
| Q3 25 | 89.5% | — | ||
| Q2 25 | 87.3% | — | ||
| Q1 25 | 88.7% | — | ||
| Q4 24 | 87.1% | — | ||
| Q3 24 | 78.9% | — | ||
| Q2 24 | 83.4% | — | ||
| Q1 24 | 81.1% | — |
| Q4 25 | 57.0% | -54.7% | ||
| Q3 25 | 22.9% | -106.9% | ||
| Q2 25 | 10.6% | -64.8% | ||
| Q1 25 | 20.3% | -102.6% | ||
| Q4 24 | 23.3% | -74.3% | ||
| Q3 24 | 11.9% | -94.6% | ||
| Q2 24 | -42.8% | -79.1% | ||
| Q1 24 | 12.2% | -151.9% |
| Q4 25 | 23.8% | -62.0% | ||
| Q3 25 | 18.7% | -112.8% | ||
| Q2 25 | 9.5% | -69.0% | ||
| Q1 25 | 17.3% | -108.5% | ||
| Q4 24 | 20.1% | -80.9% | ||
| Q3 24 | 9.7% | -95.7% | ||
| Q2 24 | -31.4% | -89.5% | ||
| Q1 24 | 9.9% | -156.8% |
| Q4 25 | $0.51 | $-1.28 | ||
| Q3 25 | $0.45 | $-1.81 | ||
| Q2 25 | $0.22 | $-1.17 | ||
| Q1 25 | $0.37 | $-1.57 | ||
| Q4 24 | $0.45 | $-1.34 | ||
| Q3 24 | $0.21 | $-1.40 | ||
| Q2 24 | $-0.66 | $-1.52 | ||
| Q1 24 | $0.20 | $-2.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $190.5M | $421.0M |
| 总债务越低越好 | $0 | — |
| 股东权益账面价值 | $374.2M | $-80.0M |
| 总资产 | $661.9M | $1.5B |
| 负债/权益比越低杠杆越低 | 0.00× | — |
8季度趋势，按日历期对齐
| Q4 25 | $190.5M | $421.0M | ||
| Q3 25 | $178.8M | $202.5M | ||
| Q2 25 | $231.2M | $176.3M | ||
| Q1 25 | $172.9M | $127.1M | ||
| Q4 24 | $304.2M | $174.0M | ||
| Q3 24 | $246.7M | $150.6M | ||
| Q2 24 | $216.2M | $480.7M | ||
| Q1 24 | $246.3M | $112.3M |
| Q4 25 | $0 | — | ||
| Q3 25 | $0 | — | ||
| Q2 25 | $0 | — | ||
| Q1 25 | $0 | — | ||
| Q4 24 | $0 | — | ||
| Q3 24 | $0 | — | ||
| Q2 24 | $0 | — | ||
| Q1 24 | $0 | — |
| Q4 25 | $374.2M | $-80.0M | ||
| Q3 25 | $375.4M | $9.2M | ||
| Q2 25 | $435.5M | $151.3M | ||
| Q1 25 | $402.1M | $144.2M | ||
| Q4 24 | $541.7M | $255.0M | ||
| Q3 24 | $483.5M | $346.8M | ||
| Q2 24 | $452.1M | $432.4M | ||
| Q1 24 | $568.4M | $140.3M |
| Q4 25 | $661.9M | $1.5B | ||
| Q3 25 | $660.5M | $1.2B | ||
| Q2 25 | $726.1M | $1.3B | ||
| Q1 25 | $689.1M | $1.3B | ||
| Q4 24 | $824.5M | $1.5B | ||
| Q3 24 | $778.2M | $1.5B | ||
| Q2 24 | $753.3M | $1.6B | ||
| Q1 24 | $870.8M | $1.3B |
| Q4 25 | 0.00× | — | ||
| Q3 25 | 0.00× | — | ||
| Q2 25 | 0.00× | — | ||
| Q1 25 | 0.00× | — | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | 0.00× | — | ||
| Q2 24 | 0.00× | — | ||
| Q1 24 | 0.00× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $83.1M | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | $81.9M | $-100.8M |
| 自由现金流率自由现金流/营收 | 39.2% | -48.6% |
| 资本支出强度资本支出/营收 | 0.6% | 0.5% |
| 现金转化率经营现金流/净利润 | 1.67× | — |
| 过去12个月自由现金流最近4个季度 | $288.9M | $-472.0M |
8季度趋势，按日历期对齐
| Q4 25 | $83.1M | $-99.8M | ||
| Q3 25 | $71.2M | $-91.4M | ||
| Q2 25 | $73.1M | $-108.3M | ||
| Q1 25 | $67.9M | $-166.5M | ||
| Q4 24 | $75.7M | $-79.3M | ||
| Q3 24 | $56.2M | $-67.0M | ||
| Q2 24 | $71.6M | $-77.0M | ||
| Q1 24 | $52.0M | $-190.7M |
| Q4 25 | $81.9M | $-100.8M | ||
| Q3 25 | $69.8M | $-92.7M | ||
| Q2 25 | $71.5M | $-110.7M | ||
| Q1 25 | $65.6M | $-167.8M | ||
| Q4 24 | $65.5M | $-79.5M | ||
| Q3 24 | $45.9M | $-68.6M | ||
| Q2 24 | $45.6M | $-79.0M | ||
| Q1 24 | $23.3M | $-193.9M |
| Q4 25 | 39.2% | -48.6% | ||
| Q3 25 | 29.2% | -58.0% | ||
| Q2 25 | 30.6% | -66.5% | ||
| Q1 25 | 29.2% | -120.5% | ||
| Q4 24 | 28.7% | -48.3% | ||
| Q3 24 | 19.8% | -49.2% | ||
| Q2 24 | 20.9% | -53.7% | ||
| Q1 24 | 10.8% | -178.2% |
| Q4 25 | 0.6% | 0.5% | ||
| Q3 25 | 0.6% | 0.8% | ||
| Q2 25 | 0.7% | 1.5% | ||
| Q1 25 | 1.0% | 1.0% | ||
| Q4 24 | 4.5% | 0.1% | ||
| Q3 24 | 4.4% | 1.2% | ||
| Q2 24 | 11.9% | 1.4% | ||
| Q1 24 | 13.3% | 3.0% |
| Q4 25 | 1.67× | — | ||
| Q3 25 | 1.59× | — | ||
| Q2 25 | 3.27× | — | ||
| Q1 25 | 1.74× | — | ||
| Q4 24 | 1.65× | — | ||
| Q3 24 | 2.50× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 2.44× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CARG
| US | $187.0M | 89% |
| Non Us | $22.1M | 11% |
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
